This is a Validated Antibody Database (VAD) review about human U2AF1L5, based on 6 published articles (read how Labome selects the articles), using U2AF1L5 antibody in all methods. It is aimed to help Labome visitors find the most suited U2AF1L5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
U2AF1L5 synonym: splicing factor U2AF 35 kDa subunit-like protein; U2 small nuclear RNA auxiliary factor 1-like protein 5; splicing factor U2AF 35 kDa subunit
Proteintech Group
| mouse monoclonal (2B7F11) |
| Proteintech Group U2AF1L5 antibody (Proteintech, 60289) was used in western blot on human samples (fig s2c). Nucleic Acids Res (2017) ncbi |
| rabbit polyclonal |
| Proteintech Group U2AF1L5 antibody (Proteintech, 10334-1-AP) was used in western blot on human samples (fig s1). Nucleic Acids Res (2017) ncbi |
| rabbit polyclonal |
| Proteintech Group U2AF1L5 antibody (Protein Tech Group, 10334-1-AP) was used in western blot on human samples . Nucleic Acids Res (2015) ncbi |
Bethyl
| rabbit polyclonal |
| In order to develop reagents to study RNA binding proteins, Bethyl U2AF1L5 antibody (Bethyl, A302-079A) was used in RNA immunoprecipitation on human samples , in immunocytochemistry on human samples at 2 ug/ml and in western blot on human samples at 0.2 ug/ml. Mol Cell (2016) ncbi |
| rabbit polyclonal |
| Bethyl U2AF1L5 antibody (Bethyl, A302-079A-1) was used in western blot on human samples (fig 3). PLoS ONE (2015) ncbi |
| rabbit polyclonal |
| In order to test how mutations affecting the 3' splice site recognition factor of U2AF1 alter its ability to splice RNA, Bethyl U2AF1L5 antibody (Bethyl Laboratories, A302-080A) was used in western blot on human samples at 1:1000 (fig 2). Genome Res (2015) ncbi |
| rabbit polyclonal |
| Bethyl U2AF1L5 antibody (Bethyl, A307-079A) was used in western blot on human samples . Mol Cell (2014) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
